In vitro endothelialization of bioprosthetic heart valves provides a cell monolayer with proliferative capacities and resistance to pulsatile flow  by Jansson, Katarina et al.
Bioprosthetic devices (eg, heart valves and vascularprostheses) are mostly fixed with glutaraldehyde, but
this treatment is believed to be partly responsible for the
lack of surface re-endothelialization as a result of toxic
effects1 and hence subsequent tissue calcification. In
human subjects there is little spontaneous growth of
endothelial cells (ECs) into implanted xenogeneic heart
valves. Nevertheless, partial in vivo re-endothelializa-
tion of bioprosthetic valves has been reported.2-4
Preoperatively in vitro endothelializing bioprostheses
with viable autologous ECs may delay or even eliminate
degenerative effects, such as tissue calcification or xeno-
geneic immunoreactivity. Techniques have been applied
to create cell linings on biologic heart valve prosthe-
ses.5,6 Glutaraldehyde preservation has, however, been
shown to be incompatible with in vitro endothelializa-
Objectives: Degeneration of bioprosthetic heart valves has been suggested to
be at least partly an immunogenic reaction toward the xenogeneic tissue. An
autologous endothelial lining has been proposed to overcome this problem.
We examined in vitro endothelialization of such tissue and retention of
endothelial cells after exposure to flow resembling the in vivo situation.
Methods: Cultured human saphenous vein endothelial cells were used to in
vitro endothelialize photo-oxidized bioprosthetic heart valves. The endothe-
lialized valves were mounted in a specially designed flow device, creating a
pulsatile flow through the valve. Maintenance of a confluent cell layer and
deposition of basement membrane markers were determined with immuno-
histochemical labeling.
Results: Labeling of the main components of the basement membrane,
laminin and collagen type IV, was verified within 6 hours after in vitro
endothelialization. Under static conditions, 4-mm wide denudations were
completely re-endothelialized in 4 days, which was similar to the growth rate
on gelatin-coated cell culture plastic, which served as a control material.
After exposure of endothelialized valves to pulsatile flows for 24 hours (80
beats/min, 3.4 L/min), there were minimal cell losses from the bioprosthe-
ses. The cell layer adapted to the pulsatile flow, as verified by rearrangement
of morphology and intracellular stress fibers.
Conclusions: This study shows the feasibility of in vitro endothelialization of
photo-oxidized bioprosthetic heart valves. The cells are able to withstand a
pulsatile flow in vitro, to develop basement membrane–like structures, and
to re-endothelialize denuded areas. This technology may be used to enhance
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out the study (kindly provided by Sulzer Carbomedics, Inc,
Austin, Tex). For the flow studies, intact PhotoFix α-biopros-
theses (Sulzer Carbomedics, Inc, Austin, Tex) (23 or 25 mm
in diameter) were used. The bioprosthetic material was stored
in alcohol and rehydrated in PBS. Before seeding, the valves
and tissues were preincubated in MEM with 30% HS for 2 to
4 hours.
Endothelialization of bioprosthetic tissue. The bovine
pericardial tissue was cut into round patches corresponding to
the size of a well in 24-well plates (1 patch per well; Costar).
Two days before experiments, the bioprosthetic tissue was
endothelialized with cultured HSVECs at a density of 1.5 ×
105 cells/cm2 in MEM containing 30% HS and antibiotics.
Endothelialization of bioprosthetic heart valves. The
intact photo-oxidized heart valves were in vitro endothelial-
ized in a stepwise fashion, essentially as described by
Bengtsson and associates.6 We used supraphysiologic cell
densities for endothelialization to achieve an immediate and
confluent cell layer. The bioprosthetic valve was mounted in
a rotating device so that each cusp could be placed in an
upright position. For endothelialization of the inflow aspect
of the valve, a cell suspension (4 × 106 HSVECs in 8 mL of
MEM with 30% HS and antibiotics, 5 × 105 HSVECs/cm2)
was allowed to adhere for 15 minutes per cusp. For endothe-
lialization of the outflow surfaces, the valve prosthesis was
turned, and thereafter another 8 mL of cell suspension (4 ×
106 HSVECs) was infused into the seeding device (15 min-
utes per cusp). In addition, the commissures were placed in
an upright position for 10 minutes each. Thereafter, the in
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tion of bioprosthetic materials. Yet several investigators
have reported enhanced cell viability by using alterna-
tive fixation procedures or detoxifying agents.5,7-9
ECs in vivo are subject to a constant pulsatile flow,
and it has been shown that endothelialized vascular
synthetic grafts show a better cell retention after shear
stress preconditioning.10 Exposing endothelialized bio-
prosthetic heart valves to pulsatile stresses in vitro may
therefore promote retention of seeded cells and thereby
possibly optimize the EC function after implantation. 
In this study we developed a flow unit in which
endothelialized heart valves can be preconditioned to a
pulsatile flow. When connected to this device, the valve
opens and closes in a manner similar to that seen in the
vivo situation. Throughout the study, we have used
bovine pericardial tissue and intact heart valves pre-
served by dye-mediated photo-oxidation, as described
by Moore and associates,11 because this material has
been shown to be compatible with cultured ECs.8 We
used experimental conditions to establish the retention
of human saphenous vein endothelial cells (HSVECs)
on in vitro endothelialized bioprosthetic heart valves
after exposure to the pulsatile flow system. In addition,
we studied re-endothelialization of denudations within
a monolayer and the deposition of basement membrane
components.
Materials and methods
Cell culture. As approved by the ethical committee at the
Karolinska Hospital, Stockholm, Sweden, residual segments
of the great saphenous vein were collected from patients
undergoing coronary bypass surgery. ECs were isolated by
rinsing veins with minimal essential medium (MEM; Gibco,
Life Technologies Ltd, Scotland, United Kingdom) and filled
with 0.1% collagenase (Worthington, Freehold, NJ) and
0.16% dispase (Boehringer Mannheim GmbH, Mannheim,
Germany) in MEM for 20 minutes at 37°C in an 8% carbon
dioxide–humidified atmosphere. Cells were collected and
thereafter cultured in MEM containing 40% heat-inactivated
pooled human serum (HS; 56°C for 30 minutes), 1 nmol/L
choleratoxin (Sigma Chemical Company, St Louis, Mo), 33
µmol/L isobutylmethylxantine (Sigma), and antibiotics (peni-
cillin, 50 U/mL, and streptomycin, 50 µg/mL; Gibco).12 The
HSVECs were seeded in gelatin-coated (0.2% in phosphate-
buffered saline solution [PBS] for 30 minutes at 4°C, Sigma)
cell culture vessels (Costar, Cambridge, Mass) and passaged
(1:3) with trypsin (0.05%) and ethylenediamine tetraacetic
acid (0.01%). The HSVECs were characterized with mono-
clonal anti-human von Willebrand factor–related antigen
(1:100; Dako, A/S, Glostrup, Denmark). HSVECs between
passages 4 and 7 were used in the experiments. 
Bioprosthetic material. Bovine pericardial tissue pre-
served with dye-mediated photo-oxidation was used through-
Fig 1. Schematic outline of the pulsatile flow device. The
endothelialized heart valve is mounted to an arm that is sub-
ject to a pendular movement by attachment to a motor. When
the arm is set in motion, a controller may adjust the frequen-
cy of the pulsatile flow. The heart valve prosthesis will open
or close, depending on the back-and-forth movement. The
length of the arm from the axis to the center of the valve is
100 mm. The total length of the pendular movement of the
valve is 873 mm.
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vitro endothelialized heart valve was kept under static condi-
tions for an additional 2 days before exposure to pulsatile
flow. The experiments were repeated 4 times with different
HSVEC donators obtaining similar results.
In vitro pulsatile flow of heart valves. The intact in vitro
endothelialized heart valve prosthesis was connected to a spe-
cially designed flow device connected to a controller that sets
an adjustable frequency and speed of a motor, hence adjust-
ing the volume of medium (MEM containing 30% HS) flow-
ing through the valve. The resulting flow opens and closes the
heart valve by means of a pendular movement (Fig 1).
Endothelialized heart valve prostheses were exposed to flow
for 24 hours (3.4 L/min, 80 beats/min) or maintained in stat-
ic culture as controls. Throughout the studies, the flow device
was placed in an incubator with 95% humidity and 8% car-
bon dioxide.
Fig 2. Verification of an intact HSVEC monolayer on the heart valve prosthesis with immunohistochemical label-
ing of CD31. A representative endothelialized cusp is shown after exposure to a pulsatile flow for 24 hours (80
beats/min, 3.4 L/min). The left panel shows schematic cusps, with filled squares indicating the position of illustra-
tions on the inflow and outflow side of the same cusp. White areas on the inflow illustrations are areas out of focus
because of the rough surface (bar = 50 µm).
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Indirect immunohistochemical labeling. Indirect
immunohistochemical labeling was used to verify the EC
monolayer and to study the basement membrane deposition
and location of intracellular stress fibers in HSVECs seeded
on bioprosthetic tissue. The monoclonal anti-human antibod-
ies used were CD31 (1:100, Dako), laminin (1:100,
Boehringer-Mannheim), collagen type IV (1:100, Dako), and
actin (1:100, Sigma). For detection, biotinylated antibodies
(1:200; Vector Laboratories, Inc, Burlingame, Calif) and
streptavidin-conjugated Cy-3 (1:200; Jackson Immuno
Research Laboratories, Inc, West Grove, Pa) or the ABC-kit
(Vector) with subsequent AEC development (Vector) were
used. All antibodies were diluted in PBS alone or in 0.3%
Triton in PBS. The heart valves were fixed in 4% formalde-
hyde in PBS; otherwise, nonfixed materials were used.
Mouse monoclonal anti-immunoglobulin G1 (1:20, Dako) or
secondary antibodies only were used as negative controls.
In vitro model for endothelial repair. Two days before in
vitro endothelialization of bioprosthetic tissue, HSVECs
were stained with 2.5 µg/mL 1,1-dioctadecyl-3,3,3´,3´-
tetramethylindocarbocyanine-perchlorate (Molecular Probes
Inc, Eugene, Ore) in cell culture medium for 30 minutes.
Before endothelialization, an area in the middle (4 × 10 mm)
was covered by a stainless steel weight to mediate a cell-free
area. Two days after in vitro endothelialization, the steel
weight was removed, and a 4-mm wide gap devoid of cells
was thus created, representing a defect in the endothelial
monolayer (regarded as day 0). HSVECs seeded on gelatin-
coated cell culture plastic (24-well plates, Costar) served as
controls. During re-endothelialization, the HSVECs were
incubated in MEM with 40% HS, choleratoxin, and isobutyl-
methylxantine to mediate proliferation.12 Re-endothelializa-
tion of the cell-free areas was verified on days 1 to 5 in a
Nikon epifluorescence microscope (Eclipse, E-800,
Yokohama, Japan). The experiment was repeated with
HSVECs isolated from 5 different donors with similar
results.
Results
Exposure to pulsatile flow.  The in vitro endothe-
lialized heart valve prosthesis was shown to maintain
an HSVEC monolayer after exposure to a pulsatile
flow for 24 hours at 80 beats/min, corresponding to 3.4
L/min passing through the valve (Fig 2). There were
essentially no cell losses after 24 hours. Only denuda-
tions a few cells wide could be seen in 1 to 3 areas per
cusp. The inflow surfaces of the cusps were rougher
than the smooth outflow surfaces, but the endothelial
lining could be followed on top of the fibrils. The
HSVECs showed some alignment, possibly because of
the pulsatile flow, and there were also minor differ-
ences in the distribution of HSVECs in the central part
of the cusps compared with the peripheral parts.
Intracellular stress fibers. The distribution of actin
in HSVECs changed after exposure of the endothelial-
Fig 3. Immunohistochemical labeling of the actin distribution in HSVECs on endothelialized heart valve leaflets
incubated under static condition (A) or exposed to a pulsatile flow for 24 hours (B). The static control showed ECs
with a cobblestone morphology, and the dense peripheral bands were more prominent compared with the flow-
exposed HSVECs (bar = 50 µm).
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ized heart valves to the pulsatile flow (80 beats/min for
24 hours). The static control showed cobblestone-
shaped HSVECs, with labeling of actin fibers in dense
peripheral bands (Fig 3, A). The HSVECs exposed to
pulsatile flow were elongated and showed less actin
labeling (ie, a less-pronounced dense peripheral band),
but staining was still mainly associated to the cell
periphery (Fig 3, B), indicating reorganization in asso-
ciation with a change in cell morphology.
Basement membrane deposition. Six hours after
confluent seeding of HSVECs on the bioprosthetic tis-
sue, there was mostly weak intracellular staining of
both laminin and collagen type IV (Fig 4, A and C).
After 24 hours in culture, laminin and collagen type IV
were deposited into the extracellular matrix, as verified
by subendothelial labeling of thin fibrils (Fig 4, B and
D). There was no apparent change in the staining pat-
tern of collagen type IV after exposure to pulsatile flow
(data not shown). 
Endothelial repair. At day 0, the endothelial mono-
layers were facing a 4-mm wide gap devoid of cells on
the bioprosthetic tissue (Fig 5, A). There was a rapid
migration-proliferation of HSVECs into the cell-free
area, and after 2 days, approximately two thirds of the
cell-free area was re-endothelialized (Fig 5, B, day 2).
Within 4 days, the re-endothelialization process was
completed, resulting in a confluent cell layer (Fig 5, C).
The growth rate was similar to that of HSVECs seeded
on gelatin-coated cell culture plastic (data not shown).
CD31 labeling confirmed the HSVECs, and individual
cells could be seen during re-endothelialization (Fig 5,
D, day 3).
Discussion
In this study we report the feasibility of confluent in
vitro endothelialization of bioprosthetic heart valves by
using cultured adult HSVECs, and we demonstrate
maintenance of the EC monolayer after exposure to an
in vitro pulsatile flow for 24 hours.
During the normal cyclic performance of the aortic
valve, its leaflets are subjected to continuous bending
and shearing stresses, as well as various pressures. The
pulsatile flow unit was developed to simulate in vivo
conditions by mediating opening and closing of the
Fig 4. Basement membrane deposition by HSVECs seeded on bioprosthetic tissue, as verified with immunofluo-
rescent labeling of laminin (A, B) and collagen type IV (C, D). Six hours after confluent endothelialization,
HSVECs showed weak staining, mostly intracellular, of both laminin (A) and collagen type IV (C). After 24 hours,
there was subendothelial labeling of both antigens (B and D), indicating a reconstituted basement membrane 
(bar = 100 µm).
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mounted heart valve in a pendular movement. In this
study we only showed the usefulness of the flow device
as a tool for studying cell retention on endothelialized
heart leaflets and did not evaluate shear stress or pres-
sure at the cuspal areas. The measurement of flow rates
reflects the volume of media passing through the valve
per time unit. In preliminary studies we used various
flow rates, ranging from 1 L/min (24 hours) to 6.5
L/min (1 hour), without having any major cell losses.
The adaptation of HSVECs to the pulsatile flow was
indicated by the change in morphology and verified by
actin reorganization. The alignment of ECs was not
uniform throughout the endothelialized cusps, indepen-
dent of inflow or outflow aspect. This suggests rather
complex flow patterns within the valve, possibly by
both longitudinal and cyclic stresses.13 Orientation of
cultured ECs during exposure to stress has been report-
ed to take up to 24 hours,14 which is similar to that
found in our model. We also noted some differences in
cell orientation between different cusps. This may be
explained by alignment of ECs with the arrangement of
collagen fibers in the cuspal tissue.15
In our experiments the endothelialized heart valves
were kept in static culture for 2 days before exposure
to shear stress. This time has been shown to mediate
deposition of basement membrane,16 as well as a
reduction in cell-adhesion molecule expression17 by
HSVECs seeded on cardiovascular materials. Reports
suggest the outcome of cell retention on vascular
grafts after exposure to flow may be influenced by
the in vitro incubation time and precoating
matrix.18,19 Preconditioning of EC-lined vascular
grafts to shear stress may also improve cell reten-
tion.10,20 Initially, a loss of cells has been reported,
but after a continued exposure, cell detachment is
gradually decreased21 and possibly counteracted by
cell proliferation.22 We did not extend our in vitro
flow studies beyond 24 hours, but during that time,
we did not see any major cell detachment. Therefore,
we believe the intact monolayer seen after 24 hours
Fig 5. Re-endothelialization by HSVECs on bioprosthetic tissue as verified with 1,1-dioctadecyl-3,3,3´,3´-tetra-
methylindocarbocyanine-perchlorate labeling (A-C). At the day of exposure (A, day 0), there was a 4-mm wide gap
devoid of cells in the endothelial monolayer. After exposure of HSVECs to the cell-free area, migration-prolifera-
tion was initiated (B, day 2), and re-endothelialization was completed within 4 days (C). Distance between lines
(A-C) is 4 mm. D, A higher magnification shows CD31 labeled HSVECs at day 3 of re-endothelialization. The
arrow represents the center of the denuded area, and the distance between the line and arrow is 2 mm.
114 Jansson et al The Journal of Thoracic and
Cardiovascular Surgery
January 2001
results from the endothelialization with HSVECs, but
we cannot exclude that proliferating cells may have
healed small denudations.
In the normal endothelium no denudations are seen,
even those only a few cells wide. High shear stresses or
mechanical disruption can easily cause endothelial
injury on endothelialized grafts. The maintenance of
differentiated functions by ECs after in vitro culture,
such as cell-matrix interactions, may well influence the
adhesive and regenerative properties of HSVECs used
for endothelialization of bioprosthetic heart valves.
Aortic EC adhesion and migration has been shown to
preferentially be promoted by collagen type IV com-
pared with laminin,23 whereas others have shown
laminin to enhance EC adhesion in a shear stress envi-
ronment.24 The rapid deposition of laminin and colla-
gen type IV by HSVECs on photo-oxidized tissue may
thus be beneficial for the EC retention on flow-exposed
endothelialized heart valves, as well as having effects
on the re-endothelialization process. It has been shown
that in vitro re-endothelialization is a combination of
proliferation and migration and also dependent on the
underlying matrix16,25 and that extracellular matrix pro-
duced by canine ECs on polytetrafluoroethylene vascu-
lar grafts promotes proliferation and shear stress resis-
tance of the cells.26 The adhesive and regenerative
capacities showed by HSVECs may be useful after
implantation of in vitro endothelialized grafts because
regrowth of an endothelial monolayer over denuded
areas as a result of, for example, minor handling trau-
ma, probably develops from an intact endothelium, as
in our re-endothelialization model.
In vitro endothelialization was performed on photo-
oxidized bioprosthetic tissue, which does not require
any detoxification except eluting ethanol, which serves
as a storage solution.11 This fixation method has been
reported to provide an EC-compatible matrix8 that is
less calcified than ordinary glutaraldehyde-fixed bio-
prosthetic material after implantation.27 Because of the
toxic actions of aldehydes, alternative fixation methods
or detoxification is needed for studies of in vitro
endothelialization. Detoxifying agents render the bio-
prosthetic tissue more cell compatible as regards pro-
liferation,28 but the attachment of cells is still limited29
and contains nonviable cells.6 Implantation of a neu-
tralized and endothelialized glutaraldehyde-fixed
xenograft valve in the nonhuman primate showed
uncoated areas despite the use of fibronectin pretreat-
ment.30 Therefore, to allow complete and durable
endothelialization, novel nontoxic materials, such as
photo-oxidized pericardium, are desirable.
In conclusion, the data presented in this study show
that photo-oxidized heart valves can be in vitro
endothelialized with adult cultured HSVECs to com-
plete confluency. The HSVECs deposit a basement
membrane structure and show regenerative properties.
Without the use of any detoxifying agents or any pre-
treatment of the valves with growth factors or adhesive
proteins (eg, fibronectin or collagen type I), the cells
were able to remain attached to the photo-oxidized bio-
material after exposure to a flow resembling the in vivo
situation. In this specially designed flow device, in
vitro endothelialized bioprostheses may be tested or
preconditioned to different pulsatile flows before
implantation.
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